Skip to main content
NVDA+0.54%AAPL-0.85%GOOGL-1.55%MSFT-0.95%AMZN-1.85%TSM-0.93%SPCX-1.82%META+0.95%AVGO-0.97%TSLA+0.33%SKHY-0.16%BRK-B+0.03%LLY+0.57%MU+0.66%JPM-1.37%WMT-0.14%AMD+2.15%V-0.43%XOM+2.44%JNJ-0.92%ASMLa-1.03%0700.HK+1.90%MA-0.60%INTC+1.67%ABBV+0.40%1398.HK-2.09%CSCO+0.72%CVX+1.91%BAC-0.28%ORCL-0.81%COST-1.14%KO-1.04%DELL+3.73%CAT-0.28%HSBA.L-2.15%0005.HK-3.21%PG+0.39%UNH-1.61%LRCX-2.21%AP2d-2.17%AMAT-1.12%1816.HK-0.46%3988.HK-2.13%NFLX-2.80%GE-2.81%MS-1.89%0857.HK+0.60%HD-1.46%PM-0.25%0939.HK-2.83%USDJPY+1.03%NZDUSD-0.95%CHFJPY+0.78%USDTHB+0.72%GBPJPY+0.70%CADJPY+0.69%GBPNZD+0.65%NZDCHF-0.62%NZDCAD-0.62%AUDUSD-0.57%EURJPY+0.52%EURUSD-0.48%EURNZD+0.48%AUDJPY+0.48%PLNJPY+0.45%NOKJPY+0.44%GBPTRY+0.41%AUDNZD+0.39%USDCAD+0.34%NZDMXN-0.33%USDCHF+0.33%SGDJPY+0.32%GBPHKD+0.32%GBPUSD-0.31%GBPMXN-0.28%USDTRY+0.25%GBPAUD+0.24%AUDCHF-0.22%USDSEK+0.21%AUDCAD-0.21%USDSGD+0.19%EURCAD-0.17%EURSEK+0.16%USDILS+0.16%NZDSGD-0.16%EURGBP-0.15%EURSGD+0.14%CHFNOK-0.14%GBPZAR-0.13%EURCHF-0.13%EURCZK+0.11%EURAUD+0.10%USDNOK+0.09%AUDDKK-0.08%NZDJPY+0.08%USDCNH+0.08%GBPSGD+0.07%USDPLN+0.07%AUDSGD+0.07%EURZAR-0.06%AUDNOK-0.05%USDDKK+0.04%EURHKD-0.04%USDCOP-0.04%GBPCAD+0.03%EURNOK+0.03%CHFSGD-0.03%USDMXN+0.02%USDHKD+0.02%CADCHF-0.02%EURPLN+0.02%USDZAR-0.01%CHFSEK-0.01%EURDKK-0.01%GBPCHF0.00%EURCNH0.00%USOIL+2.62%W1+1.91%UKOIL+1.72%XNGUSD+1.25%SUGAR-1.10%C1+1.08%COCOA-1.08%COFFEE-1.08%S1+0.93%HG1+0.43%XAUUSD-0.37%GAUUSD-0.37%BTCUSD-2.72%ETHUSD-3.95%USDTUSD-0.03%XRPUSD-2.34%SOLUSD-3.22%TRXUSDT-0.50%ZECUSDT-3.85%DOGEUSD-2.21%XMRUSDT+0.72%LINKUSD-2.58%XLMUSD+0.69%BCHUSDT-1.30%UNIUSD-3.15%LTCUSD-2.58%HBARUSDT-0.05%TONUSD+26.79%SUIUSD-2.54%TAOUSDT-3.24%AAVEUSD-2.35%DOTUSDT-2.11%ICPUSDT-7.14%ONDOUSDT-3.23%WLDUSDT-1.56%ARBUSDT+5.17%ATOMUSDT-1.85%JUPUSDT-4.30%INJUSDT-9.56%STXUSDT-3.11%FETUSDT-4.35%PYTHUSDT-4.13%TIAUSDT-6.14%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-4.12%WIFUSDT-4.80%POLUSDT+0.66%IOTAUSDT-5.86%AXSUSDT-3.20%FARTCOINUSDT-1.63%EOSUSDT-4.45%DYDXUSDT-5.96%ORDIUSDT-2.01%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-14.59%NVDA+0.54%AAPL-0.85%GOOGL-1.55%MSFT-0.95%AMZN-1.85%TSM-0.93%SPCX-1.82%META+0.95%AVGO-0.97%TSLA+0.33%SKHY-0.16%BRK-B+0.03%LLY+0.57%MU+0.66%JPM-1.37%WMT-0.14%AMD+2.15%V-0.43%XOM+2.44%JNJ-0.92%ASMLa-1.03%0700.HK+1.90%MA-0.60%INTC+1.67%ABBV+0.40%1398.HK-2.09%CSCO+0.72%CVX+1.91%BAC-0.28%ORCL-0.81%COST-1.14%KO-1.04%DELL+3.73%CAT-0.28%HSBA.L-2.15%0005.HK-3.21%PG+0.39%UNH-1.61%LRCX-2.21%AP2d-2.17%AMAT-1.12%1816.HK-0.46%3988.HK-2.13%NFLX-2.80%GE-2.81%MS-1.89%0857.HK+0.60%HD-1.46%PM-0.25%0939.HK-2.83%USDJPY+1.03%NZDUSD-0.95%CHFJPY+0.78%USDTHB+0.72%GBPJPY+0.70%CADJPY+0.69%GBPNZD+0.65%NZDCHF-0.62%NZDCAD-0.62%AUDUSD-0.57%EURJPY+0.52%EURUSD-0.48%EURNZD+0.48%AUDJPY+0.48%PLNJPY+0.45%NOKJPY+0.44%GBPTRY+0.41%AUDNZD+0.39%USDCAD+0.34%NZDMXN-0.33%USDCHF+0.33%SGDJPY+0.32%GBPHKD+0.32%GBPUSD-0.31%GBPMXN-0.28%USDTRY+0.25%GBPAUD+0.24%AUDCHF-0.22%USDSEK+0.21%AUDCAD-0.21%USDSGD+0.19%EURCAD-0.17%EURSEK+0.16%USDILS+0.16%NZDSGD-0.16%EURGBP-0.15%EURSGD+0.14%CHFNOK-0.14%GBPZAR-0.13%EURCHF-0.13%EURCZK+0.11%EURAUD+0.10%USDNOK+0.09%AUDDKK-0.08%NZDJPY+0.08%USDCNH+0.08%GBPSGD+0.07%USDPLN+0.07%AUDSGD+0.07%EURZAR-0.06%AUDNOK-0.05%USDDKK+0.04%EURHKD-0.04%USDCOP-0.04%GBPCAD+0.03%EURNOK+0.03%CHFSGD-0.03%USDMXN+0.02%USDHKD+0.02%CADCHF-0.02%EURPLN+0.02%USDZAR-0.01%CHFSEK-0.01%EURDKK-0.01%GBPCHF0.00%EURCNH0.00%USOIL+2.62%W1+1.91%UKOIL+1.72%XNGUSD+1.25%SUGAR-1.10%C1+1.08%COCOA-1.08%COFFEE-1.08%S1+0.93%HG1+0.43%XAUUSD-0.37%GAUUSD-0.37%BTCUSD-2.72%ETHUSD-3.95%USDTUSD-0.03%XRPUSD-2.34%SOLUSD-3.22%TRXUSDT-0.50%ZECUSDT-3.85%DOGEUSD-2.21%XMRUSDT+0.72%LINKUSD-2.58%XLMUSD+0.69%BCHUSDT-1.30%UNIUSD-3.15%LTCUSD-2.58%HBARUSDT-0.05%TONUSD+26.79%SUIUSD-2.54%TAOUSDT-3.24%AAVEUSD-2.35%DOTUSDT-2.11%ICPUSDT-7.14%ONDOUSDT-3.23%WLDUSDT-1.56%ARBUSDT+5.17%ATOMUSDT-1.85%JUPUSDT-4.30%INJUSDT-9.56%STXUSDT-3.11%FETUSDT-4.35%PYTHUSDT-4.13%TIAUSDT-6.14%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-4.12%WIFUSDT-4.80%POLUSDT+0.66%IOTAUSDT-5.86%AXSUSDT-3.20%FARTCOINUSDT-1.63%EOSUSDT-4.45%DYDXUSDT-5.96%ORDIUSDT-2.01%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-14.59%
MT

MapLight Therapeutics, Inc. (MPLT)

NASDAQ • Healthcare

$13.15
+$0.15 (+1.2%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$13.08
Previous Close$13.15
Day Range$12.66 - $13.45
Avg. Volume (3M)595.1K
Market Cap$530.2M
52 Week Range
$9.1$40.43
Next EarningsIn 79 daysDec 3, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$229.8M
EPS (TTM)
-$5.18
ROA (TTM)
-62.39%
Current Ratio
16.52

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-2061.6%Q4 2025-$37.18
-27.9%Q2 2026-$1.34
+2.2%Q3 2026-$1.32
Next

Dec 3

in 79 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

MapLight Therapeutics, Inc. (MPLT) is scheduled to report earnings on September 18, 2026. Wall Street expects consensus EPS of -$1.349. The company has beaten EPS in 1 of its 4 most recent quarters, putting focus on any update that shifts expectations around near-term profitability.

View full earnings history

About MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. develops clinical-stage biotechnology therapies for severe central nervous system disorders and trades on NASDAQ under the ticker MPLT. The company develops neuropsychiatric drug candidates from a proprietary platform designed to identify and modulate disease-linked neural circuits, and it operates as a subsidiary of Catalyst4, Inc.

Name
MapLight Therapeutics, Inc.
CEO
Christopher A. Kroeger
Website
www.maplightrx.com
Industry
Healthcare
Year Founded
2018
Employees
133

Today's Snapshot

AI-generated

MPLT started the session slightly lower at 13.10, while its sector was flat. MPLT is due to report earnings on 18 September.

Trading Volume

Below 10d avg (514.0K)

28.3K

vs S&P 500 Today

Strong Underperformance

-4.51%

Updated: September 15, 2026 at 14:48 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
MPLT is trading below its short-, medium- and long-term moving averages and shows downside pressure supported by a relatively strong ADX reading, while short-term momentum is negative and MACD is non-supportive. Volatility is elevated with an ATR near one dollar on a low nominal price, and the classic pivot sits above the market, marking nearby resistance. Although on-balance volume is positive, price action and moving-average alignment favor weakness. Technical takeaway: Strong sell bias as the stock trades beneath all key averages with elevated volatility and downward momentum.
All signals
  • EMA (5 indicators)$13.14 - $20.63
    Sell
  • RSI (14)38.57
    Neutral
  • Stochastic %K (14, 3, 3)55.16
    Neutral
  • MACD Level (12, 26)-1.10
    Neutral

Peers & Related Assets

DWTXDogwood Therapeutics, Inc.
EDSAEdesa Biotech, Inc.
LPCNLipocine Inc.
PMNProMIS Neurosciences, Inc.
IMRNImmuron Limited
TRAWTraws Pharma, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.